News
SOPs Page Update
By Dispex After receiving constructive feedback, we have added a “Template last updated by Dispex ” column, allowing members to easily see whether they need to replace their current SOP with...
Is there a required ink colour for GP signatures on FP10s?
By Dispex Dr Philip Koopowitz: “There is no indication about restriction of the colour of ink. Indeed NHSBSA is not mandated to check that a signature is on the script...
Diabetes – Glucagon-like Peptide-1 receptor Agonists (GLP1)
By Dispex More and more patients are being started on GLP1 agonists in an attempt to bring their diabetes and weight under control. There are 7 injectable brands, as well...
DDA Annual Conference – Update
It is now less than 10 weeks until the DDA Annual Conference which takes place at the National Conference Centre (NCC), near the NEC, Birmingham on Wednesday 24th and Thursday...
Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution, Laboratoires Théa EL(25)A/34
Source: MHRA/Gov.uk 9.7.25 Laboratoires Théa trading as Thea Pharmaceuticals Limited have notified the MHRA of an out of specification event related to environmental monitoring during manufacturing, which may increase the...
Manufacturers Rebate Scheme Changes
By Dr Philip Koopowitz – Director Dispex MDS, RWA, QE and now ePACT Over the past month we have seen 2 manufacturers move the way they deal with rebates away...
NEW Members Discount on Omnicell Clear MDS Trays!
We’re now able to offer Dispex members exclusive discounts on MDS trays directly from Omnicell! Non-members are also welcome to purchase online at standard rates. We encourage all orders to...
Brand Comparisons Update
By Dispex All Brand Comparisons have been updated in the last couple of weeks and now show the difference in profitability when prescribed generically and a brand is dispensed, where...
Keeping Medicines Safe- Room Temperature
By Dispex The Importance of Ambient Temperatures in Dispensaries With the current heatwave, many dispensing practices across the UK are facing a familiar yet critical challenge: maintaining a safe ambient...
Pop-up Reminders – The Dispex Nudger
By Dr Philip Koopowitz – Director Dispex
Personally Administered (PA) items and VAT Guidance
By Dr Philip Koopowitz – Director Dispex We frequently receive requests for guidance on Personally Administered (PA) items and VAT. To assist with this, we have compiled a list of...
Inclisiran – a further update and clarification
By Dr Philip Koopowitz – Director Dispex The reimbursement price of Inclisiran is £60.00. In addition, the DHSC has classified that all drugs from Part VIIIC – Arrangements of Payment...
